- Home
- LNTH vs TRNO Comparison
LNTH vs TRNO Comparison
Compare LNTH & TRNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- TRNO
- Stock Information
- Founded
- LNTH 1956
- TRNO 2009
- Country
- LNTH United States
- TRNO United States
- Employees
- LNTH N/A
- TRNO N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- TRNO Real Estate
- Sector
- LNTH Health Care
- TRNO Finance
- Exchange
- LNTH Nasdaq
- TRNO Nasdaq
- Market Cap
- LNTH 6.3B
- TRNO 5.9B
- IPO Year
- LNTH 2015
- TRNO 2010
- Fundamental
- Price
- LNTH $94.05
- TRNO $64.37
- Analyst Decision
- LNTH Strong Buy
- TRNO Hold
- Analyst Count
- LNTH 6
- TRNO 9
- Target Price
- LNTH $132.67
- TRNO $67.11
- AVG Volume (30 Days)
- LNTH 723.3K
- TRNO 2.0M
- Earning Date
- LNTH 02-20-2025
- TRNO 02-05-2025
- Dividend Yield
- LNTH N/A
- TRNO 2.95%
- EPS Growth
- LNTH 304.57
- TRNO N/A
- EPS
- LNTH 6.02
- TRNO 1.79
- Revenue
- LNTH $1,496,799,000.00
- TRNO $365,396,000.00
- Revenue This Year
- LNTH $19.64
- TRNO N/A
- Revenue Next Year
- LNTH $5.16
- TRNO $15.54
- P/E Ratio
- LNTH $15.62
- TRNO $35.94
- Revenue Growth
- LNTH 24.15
- TRNO 16.70
- 52 Week Low
- LNTH $50.20
- TRNO $53.78
- 52 Week High
- LNTH $126.89
- TRNO $71.63
- Technical
- Relative Strength Index (RSI)
- LNTH 53.53
- TRNO 70.11
- Support Level
- LNTH $89.92
- TRNO $57.24
- Resistance Level
- LNTH $97.25
- TRNO $60.12
- Average True Range (ATR)
- LNTH 3.42
- TRNO 1.58
- MACD
- LNTH 0.05
- TRNO 0.60
- Stochastic Oscillator
- LNTH 67.86
- TRNO 98.24
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About TRNO Terreno Realty Corporation
Terreno Realty Corp is a real estate investment trust engaged in acquiring, owning, and operating industrial real estate in six coastal U.S. markets: Los Angeles, Northern New Jersey/New York City, San Francisco Bay Area, Seattle, Miami, and Washington, D.C. The company invests in several types of industrial real estate, including warehouse/distribution, flex (including light industrial and research and development), transshipment, and improved land.